DMRA
Despite SC intensifying its focus on misleading ads, amendment to curb fake ads by drug cos delayed since 2020Supreme Court addresses misleading ads, pending amendments to DMR(OA) Act since Feb 2020 with Union health ministry. Proposed changes aim t...
Exaggerated drug ads to bring fines, stringent chargesMinistry sets up panel to suggest stronger criminal procedures against violators. At present, penalties for false claims include “imprisonm...
- Load More